Growing Adoption Spectradyne offers MRPS-based particle analysis as a faster, more accurate alternative to light scattering, with applications across life science and industrial materials. This positions them well to target labs and manufacturers seeking higher fidelity particle sizing, concentration, and fluorescence data.

Low Volume Advantage With sample requirements of only 3 microliters and the ability to analyze complex matrices directly, the technology is attractive to researchers working with precious or hard-to-obtain samples, enabling practical proof-of-concept demonstrations and faster project kickoffs.

Global Research Use MRPS is used in extracellular vesicle research, gene therapy, nanomedicine, vaccine development, liposome and lipid nanoparticle work, as well as industrial applications like polymers and coatings. This broad usage creates multiple entry points for cross-selling instruments, consumables, and support services.

Early-Stage Funding Current revenue is under $1M with $1.5M in funding, indicating a seed-to-early-stage growth phase. This suggests opportunities for strategic partnerships, co-development deals, and pilot programs with academic labs or biotech startups seeking MRPS capabilities.

Trial-Driven Engagement Spectradyne offers free measurement of a few samples to demonstrate value, a practical engagement hook for sales teams to secure conversations, collect case studies, and convert researchers into paying customers through hands-on proofs of performance.